Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Infervision Closes $47 Million B+ Round for AI-aided CT Scan Analysis

publication date: Mar 19, 2018

Infervision of Beijing raised $47 million in a B+ round to support its AI-aided CT cancer scanning software. So far, the company has developed two products, one for early detection of lung cancer and the other for detecting cardiothoracic lesions. Infervision says its products shorten the time a radiologist needs to read a scan while also increasing the accuracy of the readings. Participants in the funding were existing investors Sequoia Capital China, Qiming Venture Partners and Genesis Capital, along with new investors Xianghe Capital and Advantech Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here